CLINICAL ROLE -
Oncology Overview: Abemaciclib (Verzenio) for HR-Positive, HER2-Negative High Risk Early Breast Cancer
Abemaciclib (Verzenio; Lilly) is the first addition to adjuvant endocrine therapy approved by the FDA in two decades.
Read More
Oncology Overview: Acalabrutinib (Calquence) for Chronic Lymphocytic Leukemia
Acalabrutinib (Calquence; AstraZeneca) provides efficacy while maintaining favorable tolerability for patients with chronic lymphocytic leukemia.
Oncology Overview: Isatuximab-irfc (Sarclisa) for Relapsed/Refractory Multiple Myeloma
Isatuximab-irfc (Sarclisa; sanofi-aventis) provides patients with another option for treatment and significantly reduces the risk of disease progression or death.
Pharmacists Are Needed to Provide Birth Control
A contraception toolkit helps them improve women's reproductive health.
